EUVIMEDEUVIMED entdecken
Crossref

Machine Learning‐Based Screening of Optimal miRNA Targets Enabled by a Cytosolic Delivery Carrier for Augmenting Cancer Therapy

Hang Xu iD, Pengxiang Min, Yanbin Fu, Ge Sun, Hui Wu, Mengqiao Pan, Chaoxian Zhao, Jiatong Li, Ying Wu, Ying Xu, Bin Gu, Jiahua Pan und 2 weitere

Advanced Materials · 2026-10 · 38 (58)

DOI: 10.1002/adma.202521283 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 19.08.2026. Verfasst von Hang Xu und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital Affiliated to Shanghai Jiao Tong University School of …. Hauptthemen laut MEDLINE: MicroRNAs, Machine Learning, Prostatic Neoplasms, Cytosol. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China Youth Grant, Key Laboratory Foundation of Shanghai Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nucleic acid therapeutics offer promise for precision cancer treatment, but are limited by inaccurate target selection and inefficient delivery. This work presents a therapeutic platform combining dual machine learning models (LASSO and RSF)‐based miRNA target screening with a modular biomimetic nanocarrier system. Systematic screening and experimental validation identify miR‐873 as a previously uncharacterized tumor‐suppressive miRNA in prostate cancer, and miR‐20a as oncogenic. Mechanistic studies reveal that they regulate HNRNPK and ABL2, modulating pathways involved in proliferation and metastasis. Then, the biomimetic nanocarrier, engineered with prostate cancer cell‐derived endoplasmic reticulum membrane (ERM), is successfully developed for cytosolic co‐delivery of miR‐873 mimic and miR‐20a inhibitor in prostate cancer, achieving significant and synergistic suppression of tumor proliferation and metastasis both in vitro and in vivo. Besides, co‐loading with docetaxel further enhances antitumor effects, underscoring its potential for combination therapies to inhibit cancer progression. These findings highlight both the therapeutic synergy of rationally selected miRNA combinations and the platform's versatility for precision cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsMachine LearningProstatic NeoplasmsCytosolDrug CarriersHumansAnimalsCell Line, TumorMaleCell ProliferationNanoparticlesAntineoplastic AgentsBiomimetic MaterialsMice

Stichwörter der Autor:innen

cytosolic deliverymachine learningmiRNA therapyprostate cancer

Substanzen

MicroRNAsDrug CarriersAntineoplastic Agents

Autor:innen und Institutionen

  • State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
  • Shanghai Key Laboratory for Cancer Systems Regulation and Clinical Translation (CSRCT-SHANGHAI), Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
  • Key Laboratory of Modern Toxicology of Ministry of Education, Nanjing Medical University, Nanjing, P. R. China.
  • Department of Traditional Chinese Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
  • Department of Urology, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
  • Department of Urology, Shanghai Pudong New Area People's Hospital, Shanghai, P. R. China.

ORCID-Profile: Hang Xu, Peifeng Liu

Förderung

  • National Natural Science Foundation of China Youth Grant
  • Key Laboratory Foundation of Shanghai Cancer Institute

Zitieren

APA

Xu, H., Min, P., Fu, Y., Sun, G., Wu, H., Pan, M., Zhao, C., Li, J., Wu, Y., Xu, Y., Gu, B., Pan, J., Zhang, L., & Liu, P. (2026). Machine Learning‐Based Screening of Optimal miRNA Targets Enabled by a Cytosolic Delivery Carrier for Augmenting Cancer Therapy. Advanced Materials, 38(58). https://doi.org/10.1002/adma.202521283

Vancouver

Xu H, Min P, Fu Y, Sun G, Wu H, Pan M, et al. Machine Learning‐Based Screening of Optimal miRNA Targets Enabled by a Cytosolic Delivery Carrier for Augmenting Cancer Therapy. Advanced Materials. 2026;38(58). doi:10.1002/adma.202521283

BibTeX
@article{Xu2026,
  author = {Xu, Hang and Min, Pengxiang and Fu, Yanbin and Sun, Ge and Wu, Hui and Pan, Mengqiao and Zhao, Chaoxian and Li, Jiatong and Wu, Ying and Xu, Ying and Gu, Bin and Pan, Jiahua and Zhang, Lin and Liu, Peifeng},
  title = {Machine Learning‐Based Screening of Optimal miRNA Targets Enabled by a Cytosolic Delivery Carrier for Augmenting Cancer Therapy},
  journal = {Advanced Materials},
  year = {2026},
  volume = {38},
  number = {58},
  doi = {10.1002/adma.202521283}
}
Kostenlos starten →